TRBC1
T cell receptor beta constant 1
Also known as: BV05S1J2.2, TCRBC1, TRBC1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01850
- Gene
- TRBC1
- Ensembl
- ENSG00000211751
- Chromosome
- 7
- Canonical length
- 176 aa
- Protein class
- Predicted membrane proteins, T-cell receptor genes
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to be involved in T cell receptor signaling pathway; adaptive immune response; and alpha-beta T cell activation. Predicted to be located in plasma membrane. Predicted to be part of alpha-beta T cell receptor complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
176 residues, UniProt reviewed canonical sequence.
>P01850|TRBC1
1 DLNKVFPPEV AVFEPSEAEI SHTQKATLVC LATGFFPDHV ELSWWVNGKE VHSGVSTDPQ
61 PLKEQPALND SRYCLSSRLR VSATFWQNPR NHFRCQVQFY GLSENDEWTQ DRAKPVTQIV
121 SAEAWGRADC GFTSVSYQQG VLSATILYEI LLGKATLYAV LVSALVLMAM VKRKDFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRBC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 1,415 nTPM
Expression across tissuesHPA
Tissue
- thymus: 1,415 nTPM
- lymph node: 302 nTPM
- tonsil: 213 nTPM
- appendix: 132 nTPM
- spleen: 87 nTPM
- bone marrow: 50 nTPM
Single-cell type
- t-cells: 232 nCPM
- innate lymphoid cells: 165 nCPM
- nk-cells: 148 nCPM
- pdcs: 15 nCPM
- thymocytes: 13 nCPM
- leydig cells: 11 nCPM
Immune cell
- T-reg: 3,242 nTPM
- naive CD4 T-cell: 1,996 nTPM
- total PBMC: 1,919 nTPM
- memory CD4 T-cell: 1,899 nTPM
- naive CD8 T-cell: 1,456 nTPM
- memory CD8 T-cell: 1,259 nTPM
Brain region
- white matter: 2.4 nTPM
- medulla oblongata: 2.3 nTPM
- spinal cord: 2 nTPM
- pons: 1.8 nTPM
- thalamus: 1.7 nTPM
- basal ganglia: 1.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRBC1.
Disease | ImmuneIEDB
Conditions an epitope on TRBC1 was assayed in.
- rheumatoid arthritis B cell
OntologyGO
Biological processes
- adaptive immune response
- alpha-beta T cell activation
- immune response
- T cell receptor signaling pathway
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRBC1 as an antibody target. Whether an autoantibody or antibody against TRBC1 could matter depends on whether native TRBC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRBC1 is annotated at the cell surface, where native TRBC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRBC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...